Cervical Cancer Screening in Elderly Women

Main Article Content

Tharangrut Hanprasertpong
Kriengsak Dhanaworavibul
Kittinun Leetanaporn
Jitti Hanprasertpong

Abstract

Cervical cancer (CC) is the one of the leading causes of cancer death among women worldwide. Globally, with the current projections for increases in life expectancy, the prevalence of CC in elderly women is expected to rise, increasing the desirability of CC screening to detect the disease at an earlier stage in this group. However, making the decision to screen for CC in elderly women is often difficult and complex. The decision needs to be made using the best available evidence and a personalized assessment that integrates factors unique to elderly women with the aim to weigh the risks and benefits for each woman. The recent 2020 United States guideline update from the American Cancer Society recommends against cervical screening beyond age 65 in women who have had adequate negative screening results. Despite the evidence cited for this recommendation, implementation in a clinical practice guideline can be challenging, with resistance from elderly women and clinicians. Following is a brief review of current knowledge concerning the CC screening in elderly women. We also review the benefits and risks of CC screening in women older than 65 years.

Article Details

How to Cite
(1)
Hanprasertpong, T.; Dhanaworavibul, K. .; Leetanaporn, K. .; Hanprasertpong, J. . Cervical Cancer Screening in Elderly Women. Thai J Obstet Gynaecol 2022, 30, 370-375.
Section
Special Article

References

Cancer IAfRo. Cancer incidence in five continents time trends. https://ci5.iarc.fr/CI5plus/Pages/online.aspx. Accessed 20 Sep 2022.

Chittithaworn S, Hanprasertpong J, Tungsinmunkong K, Geater A. Association between prognostic factors and disease-free survival of cervical cancer stage IB1 patients undergoing radical hysterectomy. Asian Pac J Cancer Prev 2007;8:530-4.

Tangkananan A, Thongkhao P, Janmunee N, Hanprasertpong J. Impact of chemotherapy cycles on oncological outcomes in elders with locally advanced cervical cancer treated with concurrent chemoradiotherapy. J Med Imaging Radiat Oncol 2022;66:1014-21.

Chittithaworn S, Charakorn C, Kongsawatvorakul C. Cervical cancer screening guidelines: An updated review. Thai J Obstet Gynaecol 2021;29:186-90.

Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet 2017;389:1323-35.

Hou P, Hsieh C, Wei M, Hsiao S, Shueng P. Differences in treatment outcomes and prognosis between elderly and younger patients receiving definitive radiotherapy for cervical cancer. Int J Environ Res Public Health 2020;17:4510.

Feldman S, Cook E, Davis M, Gershman ST, Hanchate A, Haas JS, et al. Cervical cancer incidence among elderly women in Massachusetts compared with younger women. J Low Genit Tract Dis 2018;22:314-7.

Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy 2019;18:29-37.

Ioka A, Tsukuma H, Ajiki W, Oshima A. Influence of age on cervical cancer survival in Japan. Jpn J Clin Oncol 2005;35:464-9.

Eggemann H, Ignatov T, Geyken CH, Seitz S, Ignatov A. Management of elderly women with cervical cancer. J Cancer Res Clin Oncol 2018;144:961-7.

Sawaya GF, Brown AD, Washington AE, Garber AM. Clinical practice. Current approaches to cervical-cancer screening. N Engl J Med 2001;344:1603-7.

Dinkelspiel H, Fetterman B, Poitras N, Kinney W, Cox JT, Lorey T, et al. Screening history preceding a diagnosis of cervical cancer in women age 65 and older. Gynecol Oncol 2012;126:203-6.

Alibhai SMH, Horgan AM. Cancer screening in older adults: What to do when we don't know? J Geriatr Oncol 2011;2:149-60.

Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin 2020;70:321-46.

Wang W, Arcà E, Sinha A, Hartl K, Houwing N, Kothari S. Cervical cancer screening guidelines and screening practices in 11 countries: A systematic literature review. Prev Med Rep 2022;28:101813.

Gravitt PE, Landy R, Schiffman M. How confident can we be in the current guidelines for exiting cervical screening? Prev Med 2018;114:188-92.

Mossa MA, Carter PG, Barton DP, Young MP. Cervical intraepithelial neoplasia in postmenopausal women: difficulties in cytology, colposcopy and treatment. The Obstetrician & Gynaecologist 2001;3:8-12.

Dilley S, Huh W, Blechter B, Rositch AF. It's time to re-evaluate cervical cancer screening after age 65. Gynecol Oncol 2021;162:200-2.

Rositch AF, Silver MI, Gravitt PE. Cervical cancer screening in older women: new evidence and knowledge gaps. PLoS Med 2014;11:e1001586.

Lam JU, Lynge E, Njor SH, Rebolj M. Hysterectomy and its impact on the calculated incidence of cervical cancer and screening coverage in Denmark. Acta Oncol 2015;54:1136-43.

Rositch AF, Nowak RG, Gravitt PE. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer 2014;120:2032-8.

Dinkelspiel H, Fetterman B, Poitras N, Kinney W, Cox JT, Lorey T, et al. Screening history preceding a diagnosis of cervical cancer in women age 65 and older. Gynecol Oncol 2012;126:203-6.

Hammer A, Soegaard V, Maimburg RD, Blaakaer J. Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-A national cohort study. Cancer Med 2019;8:418-27.

Yost S, Hoekstra A. Cervical cancer in women over 65: An analysis of screening. Gynecol Oncol Rep 2018;25:48-51.

Castañón A, Landy R, Cuzick J, Sasieni P. Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study. PLoS Med 2014;11:e1001585.

Paul P, Hammer A, Rositch AF, Burke AE, Viscidi RP, Silver MI, et al. Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior. J Infect Dis 2021;223:1423-32.

Shen Y, Xia J, Li H, Xu Y, Xu S. Human papillomavirus infection rate, distribution characteristics, and risk of age in pre- and postmenopausal women. BMC Womens Health 2021;21:80.

Eun TJ, Perkins RB. Screening for cervical cancer. Med Clin North Am 2020;104:1063-78.

Gilham C, Crosbie EJ, Peto J. Cervical cancer screening in older women. BMJ 2021;372:n280.

Lindström AK, Hermansson RS, Gustavsson I, Hedlund Lindberg J, Gyllensten U, Olovsson M. Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing. PLoS One 2018;13:e0207714.